Title: Expression of fibroblast growth factor receptors in hepatocellular carcinoma
Abstract: Fibroblast growth factor receptors (FGFRs) are generated from four genes (FGFR1/2/3/4). Alternative splicing of FGFR1-3 creates b- and c-isoforms that differ in ligand-binding and thus further enhance the complexity of FGF-signalling. FGFR-inhibition has been shown to inhibit progression of hepatocellular carcinoma (HCC) in experimental models. However, existing clinical studies with mostly unspecific FGFR-pan-inhibitors in non-selected patient-cohorts have not shown beneficial effects on survival.
Publication Year: 2022
Publication Date: 2022-01-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot